Anti-beta Amyloid 1-40 antibody [BDI350]
3
(3 Reviews)
|
(10 Publications)
Mouse Monoclonal Amyloid-beta precursor protein antibody. Suitable for WB and reacts with Synthetic peptide - Human samples. Cited in 10 publications. Immunogen corresponding to Synthetic Peptide within Human APP conjugated to Keyhole Limpet Haemocyanin.
View Alternative Names
A4, AD1, APP, Amyloid-beta precursor protein, ABPP, APPI, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid precursor protein, Amyloid-beta (A4) precursor protein, Amyloid-beta A4 protein, Cerebral vascular amyloid peptide, PreA4, Protease nexin-II, CVAP, PN-II
- WB
Unknown
Western blot - Anti-beta Amyloid 1-40 antibody [BDI350] (AB20068)
All lanes:
Western blot - Anti-beta Amyloid 1-40 antibody [BDI350] (ab20068) at 2 µg/mL
Lane 1:
Beta Amyloid peptide 1-40
Lane 2:
Beta Amyloid peptide 1-42
Lane 3:
Beta Amyloid peptide 1-43
Predicted band size: 86 kDa
true
Exposure time: 30s
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Small soluble oligomers of beta amyloid interact with neuronal cells leading to synaptic dysfunction and cell death. Beta amyloid 1-40 molecules do not normally function in isolation; they often assemble into beta amyloid plaques a complex structure that can contribute to cellular anomalies. Amyloid beta production and its aggregation play parts in a process that disrupts neural communication impacting memory and learning processes.
Pathways
The amyloidogenic pathway involves beta amyloid where amyloid precursor protein (APP) is cleaved by beta-secretase and gamma-secretase to generate beta amyloid peptides including amyloid beta 40. This molecule is associated with the oxidation and inflammation pathways where it can interact with other proteins like presenilin. Presenilin is a part of the gamma-secretase complex that influences amyloid production thereby affecting the pathological aggregation process.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Neural regeneration research 17:2079-2088 PubMed35142700
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 12:2185 PubMed33846335
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Alzheimer's disease : JAD 78:699-709 PubMed33016902
2020
Applications
Unspecified application
Species
Unspecified reactive species
PeerJ 7:e8219 PubMed31844591
2019
Applications
Unspecified application
Species
Unspecified reactive species
Brain, behavior, and immunity 75:163-180 PubMed30389461
2018
Applications
Unspecified application
Species
Unspecified reactive species
Brain pathology (Zurich, Switzerland) 29:176-192 PubMed30192999
2018
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 8:4210-4225 PubMed30128048
2018
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 13:e0190350 PubMed29324783
2018
Applications
Unspecified application
Species
Unspecified reactive species
Journal of inorganic biochemistry 152:206-9 PubMed26213226
2015
Applications
Unspecified application
Species
Unspecified reactive species
Ultramicroscopy 109:923-8 PubMed19345496
2009
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com